Screener
Larimar Therapeutics LRMR Q2 2026 earnings
Reported August 4, 2026 · Before market open
EPS-$0.30Beat by $0.08
EPS estimate-$0.38
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.39
Versus estimates
Diluted EPS
FAQ
- When did Larimar Therapeutics report Q2 2026 earnings?
- Larimar Therapeutics (LRMR) reported Q2 2026 earnings on August 4, 2026 before market open.
- What were Larimar Therapeutics's Q2 2026 revenue and EPS?
- Larimar Therapeutics reported eps of $-0.30 for Q2 2026.
- Did Larimar Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.38 by $0.08.
- How did Larimar Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 26.8% from $-0.41.
- Where can I find Larimar Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-331516) and the 10-Q periodic report (0001193125-26-331529) directly on SEC EDGAR. The filing index links above go to sec.gov.
